Humacyte, Inc. (HUMA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $39.93M2021: $217.50M2022: $149.77M2023: $80.45M2024: $44.94M2025: $50.50M$50.50M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$50.50M+12.4%
2024$44.94M-44.1%
2023$80.45M-46.3%
2022$149.77M-31.1%
2021$217.50M+444.7%
2020$39.93M